Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Dybul

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
The Lancet. HIV|December 3, 2020
Multi-stakeholder consensus on a target product profile for an HIV cureSharon R Lewin, Timothy Attoye, Cathy Bansbach, et al.
The Journal of Infectious Diseases|May 15, 2004
A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infectionMark Dybul, Elizabeth Nies-Kraske, Robin Dewar, et al.
The Lancet. HIV|December 3, 2020
The case for an HIV cure and how to get thereMark Dybul, Timothy Attoye, Solange Baptiste, et al.
Gene Therapy|September 29, 2021
Correction: Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)Jennifer E Adair, Lindsay Androski, Lois Bayigga, et al.
The Journal of Infectious Diseases|May 13, 2009
Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapyElizabeth Nies-Kraske, Timothy W Schacker, David Condoluci, et al.
Gene Therapy|September 8, 2021
Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)Jennifer E Adair, Lindsay Androski, Lois Bayigga, et al.
PLOS Global Public Health|October 17, 2024
Mpox: Neglect has led to a more dangerous virus now spreading across borders, harming and killing people. Leaders must take action to stop mpox nowChristine McNab, Els Torreele, Ayoade Alakija, et al.
Plos Medicine|June 8, 2021
Ending AIDS as a public health threat by 2030: Time to reset targets for 2025Paul R De Lay, Adèle Benzaken, Quarraisha Abdool Karim, et al.
Journal of the International AIDS Society|March 10, 2026
Integrating HIV services in an era of global changeJirair Ratevosian, Linda-Gail Bekker, Robyn Eakle, et al.
Annals of Internal Medicine|March 30, 2026
The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized TrialGilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
The Lancet. HIV|December 3, 2020
Multi-stakeholder consensus on a target product profile for an HIV cureSharon R Lewin, Timothy Attoye, Cathy Bansbach, et al.
The Journal of Infectious Diseases|May 15, 2004
A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infectionMark Dybul, Elizabeth Nies-Kraske, Robin Dewar, et al.
The Lancet. HIV|December 3, 2020
The case for an HIV cure and how to get thereMark Dybul, Timothy Attoye, Solange Baptiste, et al.
Gene Therapy|September 29, 2021
Correction: Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)Jennifer E Adair, Lindsay Androski, Lois Bayigga, et al.
The Journal of Infectious Diseases|May 13, 2009
Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapyElizabeth Nies-Kraske, Timothy W Schacker, David Condoluci, et al.
Gene Therapy|September 8, 2021
Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)Jennifer E Adair, Lindsay Androski, Lois Bayigga, et al.
PLOS Global Public Health|October 17, 2024
Mpox: Neglect has led to a more dangerous virus now spreading across borders, harming and killing people. Leaders must take action to stop mpox nowChristine McNab, Els Torreele, Ayoade Alakija, et al.
Plos Medicine|June 8, 2021
Ending AIDS as a public health threat by 2030: Time to reset targets for 2025Paul R De Lay, Adèle Benzaken, Quarraisha Abdool Karim, et al.
Journal of the International AIDS Society|March 10, 2026
Integrating HIV services in an era of global changeJirair Ratevosian, Linda-Gail Bekker, Robyn Eakle, et al.
Annals of Internal Medicine|March 30, 2026
The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized TrialGilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
Pageof 7